https://pharmadog.xyz/news/509019 pharmadog en 2026-10-07T15:37:00.000Z Caribou Biosciences halts CAR-T programs and cuts staff amid funding shortfall https://pharmadog.xyz/news/508955 pharmadog en 2026-10-07T15:24:58.000Z Bexorg receives $28 million ARPA-H grant to extend testing of revived human brain tissue https://pharmadog.xyz/news/509020 pharmadog en 2026-10-07T15:21:00.000Z Dutch court blocks Merck's subcutaneous Keytruda sales in eight European countries after Halozyme patent win https://pharmadog.xyz/news/508956 pharmadog en 2026-10-07T15:20:53.000Z Nuvig Therapeutics halts Phase 2 trial of NVG-2089 in chronic inflammatory demyelinating polyneuropathy https://pharmadog.xyz/news/508811 pharmadog en 2026-10-07T14:44:27.000Z Cerevance's solengepras cuts Parkinson off-time by 0.6 hours in Phase 3, advancing toward FDA review https://pharmadog.xyz/news/508831 pharmadog en 2026-10-07T14:06:29.000Z Dutch court blocks Merck's subcutaneous Keytruda in several European markets https://pharmadog.xyz/news/508787 pharmadog en 2026-10-07T14:03:57.000Z Novartis-partnered Matchpoint Therapeutics raises $150 million Series B to fund clinical entry https://pharmadog.xyz/news/508643 pharmadog en 2026-10-07T13:44:19.000Z ArriVent BioPharma's Phase 3 lung cancer trial misses primary endpoint, shares tumble https://pharmadog.xyz/news/508663 pharmadog en 2026-10-07T13:42:22.000Z Forbion secures $2.6 billion in its biggest European venture fund to date https://pharmadog.xyz/news/508664 pharmadog en 2026-10-07T13:38:52.000Z Utah health AI pilots face regulatory uncertainty as FDA scrutiny looms https://pharmadog.xyz/news/508495 pharmadog en 2026-10-07T12:56:49.000Z WHO issues first global guidelines on childhood and adolescent obesity https://pharmadog.xyz/news/508475 pharmadog en 2026-10-07T12:24:13.000Z Biotech VC Forbion raises record €2.3 bn ($2.6 bn) to back 30 high-potential life-science companies https://pharmadog.xyz/news/508496 pharmadog en 2026-10-07T12:10:42.000Z DOJ expands fraud enforcement to include drug and device makers under FD&C Act https://pharmadog.xyz/news/508476 pharmadog en 2026-10-07T12:05:58.000Z Caribou Biosciences to halt R&D and cut staff as financing for allogeneic CAR-T dries up https://pharmadog.xyz/news/508515 pharmadog en 2026-10-07T12:01:00.000Z Cerevance reports positive Phase 3 results for Parkinson’s drug solengepras https://pharmadog.xyz/news/508451 pharmadog en 2026-10-07T12:00:43.000Z MimiVax's glioblastoma vaccine falls short of Phase 2b primary endpoint https://pharmadog.xyz/news/508452 pharmadog en 2026-10-07T12:00:40.000Z TCGX launches $600 million Asia-focused biotech fund to back life-science companies in China and the region https://pharmadog.xyz/news/508327 pharmadog en 2026-10-07T11:50:41.000Z ER visits by foreign-born patients fall sharply after increased ICE raids in Los Angeles https://pharmadog.xyz/news/123087 pharmadog en 2026-10-07T11:31:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/508308 pharmadog en 2026-10-07T11:27:00.000Z Bayer invests $2.2 billion in Ohio to build pharma manufacturing plant https://pharmadog.xyz/news/508930 pharmadog en 2026-10-07T11:27:00.000Z ARPA-H launches Surpass program to speed and broaden clinical trials https://pharmadog.xyz/news/508283 pharmadog en 2026-10-07T11:17:25.000Z CAR-T biotech Caribou Biosciences halts two programs and seeks exit after funding shortfall https://pharmadog.xyz/news/508159 pharmadog en 2026-10-07T10:42:28.000Z 2026 Nobel Chemistry Prize honors research on chiral molecules with implications for drug development https://pharmadog.xyz/news/508762 pharmadog en 2026-10-07T10:22:00.000Z TCGX raises $600 million to fund Asian biotech startups https://pharmadog.xyz/news/508763 pharmadog en 2026-10-07T10:10:00.000Z Cerevance's solengepras cuts OFF time in phase 3 Parkinson's trial https://pharmadog.xyz/news/507971 pharmadog en 2026-10-07T09:42:29.000Z Epkinly shows 51% lower risk of progression in frontline DLBCL trial, boosting hopes for expanded approval https://pharmadog.xyz/news/508594 pharmadog en 2026-10-07T09:10:00.000Z Atsena reports early efficacy signals for gene therapy ATSN-201 in X-linked retinoschisis trial https://pharmadog.xyz/news/507718 pharmadog en 2026-10-07T08:30:00.000Z Life insurers deem active-surveillance prostate cancer 'untreated' and deny term coverage, says patient https://pharmadog.xyz/news/507715 pharmadog en 2026-10-07T08:30:00.000Z Caribou Biosciences shuts down after failing to fund late-stage CAR-T lymphoma trial https://pharmadog.xyz/news/507717 pharmadog en 2026-10-07T08:30:00.000Z Democrats court new Make America Healthy Again voters with food and environmental proposals https://pharmadog.xyz/news/507716 pharmadog en 2026-10-07T08:30:00.000Z Experimental exon-skipping drug from Avidity Biosciences shows early improvement in a Duchenne patient https://pharmadog.xyz/news/508595 pharmadog en 2026-10-07T08:16:00.000Z Matchpoint Therapeutics raises $150M Series B to advance oral covalent therapies for autoimmune disease https://pharmadog.xyz/news/507191 pharmadog en 2026-10-07T05:01:00.000Z Executive candidates need full truth, not a sales pitch, to address company challenges https://pharmadog.xyz/news/507023 pharmadog en 2026-10-07T04:06:00.000Z Venture capital continues to flow into biopharma in Q3 2026, favoring later-stage and AI-driven companies https://pharmadog.xyz/news/508937 pharmadog en 2026-10-07T02:17:00.000Z Stryker appoints Spencer Stiles as CEO, Kevin Lobo to become Executive Chair https://pharmadog.xyz/news/506095 pharmadog en 2026-10-06T23:41:30.000Z Infectious disease expert urges calm over mysterious pneumonia case in Siberia https://pharmadog.xyz/news/505439 pharmadog en 2026-10-06T20:26:16.000Z Utah expands AI prescribing sandbox to boost health‑tech innovation https://pharmadog.xyz/news/505163 pharmadog en 2026-10-06T19:00:20.000Z Secretive new issue links diverse groups, raises concerns for pharma industry https://pharmadog.xyz/news/507646 pharmadog en 2026-10-06T18:21:00.000Z Caribou Biosciences halts pipeline and announces major workforce cut https://pharmadog.xyz/news/505059 pharmadog en 2026-10-06T18:04:00.000Z Forbion raises $2.6 billion for two European biotech venture funds https://pharmadog.xyz/news/508426 pharmadog en 2026-10-06T16:22:00.000Z MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’ https://pharmadog.xyz/news/504723 pharmadog en 2026-10-06T16:12:00.000Z ArriVent shares tumble as lung cancer trial of furmonertinib misses primary goal https://pharmadog.xyz/news/134233 pharmadog en 2026-10-06T15:49:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/504555 pharmadog en 2026-10-06T15:42:00.000Z AbbVie/Genmab’s Epkinly halves progression risk in frontline DLBCL trial https://pharmadog.xyz/news/504491 pharmadog en 2026-10-06T15:28:00.000Z AstraZeneca opens 570,000-sq-ft R&D campus in Cambridge, targeting 2,000 staff https://pharmadog.xyz/news/504323 pharmadog en 2026-10-06T14:47:37.000Z ArriVent's lead lung cancer drug firmonertinib fails Phase 3 trial, shares plunge https://pharmadog.xyz/news/504367 pharmadog en 2026-10-06T14:41:00.000Z AstraZeneca launches $1 billion R&D hub in Boston’s Kendall Square https://pharmadog.xyz/news/504368 pharmadog en 2026-10-06T14:30:00.000Z Trump proposes $90 monthly aid for seniors as stem cell therapies gain attention https://pharmadog.xyz/news/504970 pharmadog en 2026-10-06T14:21:00.000Z Nuvig Therapeutics pauses CIDP trial of NVG-2089, cites enrollment and cost challenges https://pharmadog.xyz/news/504369 pharmadog en 2026-10-06T14:13:12.000Z Hospitals Launch Cash‑Pay Longevity Clinics, Offering Intensive Health Monitoring https://pharmadog.xyz/news/504350 pharmadog en 2026-10-06T14:10:59.000Z Epkinly shows 51% PFS boost in frontline DLBCL, may become new standard of care https://pharmadog.xyz/news/504111 pharmadog en 2026-10-06T13:59:08.000Z FDA outlines roadmap for AI guidance to be released in 2027 https://pharmadog.xyz/news/504112 pharmadog en 2026-10-06T13:36:42.000Z U.S. government launches first federally funded ibogaine trials for opioid addiction and PTSD https://pharmadog.xyz/news/504067 pharmadog en 2026-10-06T13:33:07.000Z KymaThera secures $80M Series B to advance oral PI3Kα inhibitor K-1728 as biotech peers raise funds and go public https://pharmadog.xyz/news/509078 pharmadog en 2026-10-06T13:30:00.000Z Leader Formulas recalls RAPTURE pre-workout supplement after FDA finds DMAA in product https://pharmadog.xyz/news/504091 pharmadog en 2026-10-06T13:11:22.000Z Compliance worries keep AI adoption in drug manufacturing low, survey finds https://pharmadog.xyz/news/503899 pharmadog en 2026-10-06T12:46:45.000Z Forbion raises €2.3 billion with Lilly backing, launches largest Dutch VC fund to back ~30 life-science firms https://pharmadog.xyz/news/503900 pharmadog en 2026-10-06T12:00:43.000Z AI investments in healthcare delivering returns faster than executives anticipated https://pharmadog.xyz/news/80789 pharmadog en 2026-10-06T12:00:00.000Z Season 2 of The Progress Profile podcast spotlights Alzheimer’s research and patient-centered trial design https://pharmadog.xyz/news/503795 pharmadog en 2026-10-06T12:00:00.000Z Key Biopharma Conferences to Watch in 2027 Highlight Industry Trends https://pharmadog.xyz/news/503775 pharmadog en 2026-10-06T11:36:10.000Z When to get your flu shot: key factors to consider https://pharmadog.xyz/news/503731 pharmadog en 2026-10-06T11:05:14.000Z AbbVie and Genmab's Epkinly succeeds in late-stage first-line DLBCL trial, challenging Roche's Polivy https://pharmadog.xyz/news/504467 pharmadog en 2026-10-06T10:51:00.000Z ArriVent’s phase 3 EGFR inhibitor trial misses primary endpoint, shares plunge 57% https://pharmadog.xyz/news/503627 pharmadog en 2026-10-06T10:38:00.000Z GE HealthCare to buy Sofie Biosciences for $945 million, boosting U.S. PET radiopharma capacity https://pharmadog.xyz/news/504042 pharmadog en 2026-10-06T08:59:00.000Z Kairos pushes prostate cancer drug ENV-105 into earlier treatment line after promising mid-phase data https://pharmadog.xyz/news/503272 pharmadog en 2026-10-06T08:30:00.000Z Doctor warns AI-driven documentation may boost hospital bills without improving care https://pharmadog.xyz/news/503271 pharmadog en 2026-10-06T08:30:00.000Z Study finds pulse oximeters at Johns Hopkins shifted from overestimating to underestimating oxygen, with larger errors in patients of color https://pharmadog.xyz/news/503273 pharmadog en 2026-10-06T08:30:00.000Z Experts warn FDA against approving Grail’s ineffective multicancer blood test https://pharmadog.xyz/news/503274 pharmadog en 2026-10-06T08:30:00.000Z Nonprofit hospitals launch pricey longevity clinics offering personalized health assessments https://pharmadog.xyz/news/503227 pharmadog en 2026-10-06T08:21:13.000Z Lycia Therapeutics files for IPO to fund antibody degrader platform https://pharmadog.xyz/news/504802 pharmadog en 2026-10-06T08:10:00.000Z Abbott receives FDA clearance for CardioMEMS HF System updates enabling home pressure monitoring via smartphone app https://pharmadog.xyz/news/503874 pharmadog en 2026-10-06T07:45:00.000Z Forbion raises record €2.3 billion to back 30 European biotech firms https://pharmadog.xyz/news/503370 pharmadog en 2026-10-06T05:09:00.000Z AstraZeneca opens 570,000-sq-ft Kendall Square R&D hub to boost cancer and biotech research https://pharmadog.xyz/news/502491 pharmadog en 2026-10-06T04:01:00.000Z BioSpace honors 40 emerging leaders shaping biopharma with breakthroughs in mRNA, gene and cell therapies https://pharmadog.xyz/news/503371 pharmadog en 2026-10-06T03:52:00.000Z TRex Bio targets $111M IPO as Retension and Lycia also prepare public listings https://pharmadog.xyz/news/503875 pharmadog en 2026-10-06T02:33:00.000Z UK regulator to shift from one-off checks to continuous monitoring of AI medical devices https://pharmadog.xyz/news/505850 pharmadog en 2026-10-06T00:00:00.000Z UK regulator adopts AI framework for medical devices and launches third AI Airlock phase https://pharmadog.xyz/news/506461 pharmadog en 2026-10-06T00:00:00.000Z UK regulator adopts AI framework for medical devices, launches next phase of AI sandbox https://pharmadog.xyz/news/505849 pharmadog en 2026-10-06T00:00:00.000Z WHO releases updated draft guideline to strengthen quality risk management for manufacturers and regulators https://pharmadog.xyz/news/506490 pharmadog en 2026-10-05T23:27:00.000Z Nova Biomedical issues global correction for StatStrip Glucose Hospital Meter over software patient-ID error https://pharmadog.xyz/news/504466 pharmadog en 2026-10-05T21:10:00.000Z Mimetic Medicines' peptide reduces pain-related sodium channels in mice, offering new neuropathic pain strategy https://pharmadog.xyz/news/501059 pharmadog en 2026-10-05T20:13:42.000Z Federal Appeals Judges Reject HHS Arguments in Humana Medicare Advantage Audit Lawsuit https://pharmadog.xyz/news/501060 pharmadog en 2026-10-05T20:08:24.000Z Nobel-winning optogenetics opens path to experimental therapies for blindness and Alzheimer’s https://pharmadog.xyz/news/500847 pharmadog en 2026-10-05T19:40:45.000Z Leerink analyst downgrades Bristol Myers over pipeline concerns https://pharmadog.xyz/news/500679 pharmadog en 2026-10-05T18:58:14.000Z Genentech parts ways with global AI head Richard Bonneau https://pharmadog.xyz/news/500723 pharmadog en 2026-10-05T18:33:57.000Z Trump administration issues new rules to standardize health-insurance pricing disclosures https://pharmadog.xyz/news/500703 pharmadog en 2026-10-05T18:24:33.000Z Viking Therapeutics jumps 24% after Phase 1 obesity data, Longeveron falls 64% on mid-stage setback https://pharmadog.xyz/news/500279 pharmadog en 2026-10-05T16:38:08.000Z Staggering health insurance premiums force employers to rethink coverage options